NEW YORK--(BUSINESS WIRE)--March 3, 2006--FermaVir Pharmaceuticals, Inc., (OTCBB:FMVR), committed to the development of breakthrough antiviral and other drug therapies, announced the appointment of veteran financial and biotech industry executive Frederick Larcombe as Chief Financial Officer.
